Raymond James Financial Inc Bridge Bio Pharma, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 16,631 shares of BBIO stock, worth $557,803. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,631Holding current value
$557,803% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
296Shares Held
171MCall Options Held
10.4MPut Options Held
2.33M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$847 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$843 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$476 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$418 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$204 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.97B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...